Biointron

April 15, 2026

Biointron Launches Comprehensive Antibody Developability Assessment Platform to Accelerate Biologic Drug Discovery

CAMBRIDGE, MA - April 15, 2026 - PRESSADVANTAGE - Biointron, an antibody contract research organization, launched a new developability platform...
Read More

Press Advantage powers agency growth through premium press release distribution that turns content into client wins.

Since 2011, we’ve helped over 2,900 agencies amplify results for their 18,300+ clients, securing more than 23 million media placements that build authority and drive rankings.

Our agency-first platform delivers the high-impact backlinks and media coverage your clients expect, without the manual outreach grind.

While other agencies chase one-off links, our partners leverage automation and guaranteed placements to scale their business faster, retain more clients, and transform press releases into predictable revenue growth.

How It Works
Who It´s For
Pricing
About
Distribution
FAQ
Resources
- Blog
- Blueprints

Other

Privacy Policy
Terms of Service
Copyright Policy
FAQs
Submission Guidelines
Distribution
Newsroom
Login

Download Your Expert-Crafted Blueprint

Enter your name and email to instantly download the resource.

We respect your privacy. Unsubscribe at any time.

About Biointron

Contact Biointron

Biointron

Biointron Launches Comprehensive Antibody Developability Assessment Platform to Accelerate Biologic Drug Discovery

Download Your Expert-Crafted Blueprint

Presentation Video